You need to differentiate between textbook and
You need to differentiate between textbook and reality
what you described is true of a large % of pennies
No shareholder meetings,
many pennies dont have shareholder meetings-very few such meetings by either pennies or bluechips are not controlled by the companies-such meetings are not held until mgmt believes they have a solid control over the outcome-only ones which dont involve hostile takeovers
keeping patents in his own name-
been over this countless times-its normal for inventors to keep patents in own name-by coercion and duress employees are often required to sign forms that work for the co resulting in patents belongs to the co
btw the inventors ownership acts like a guard against a hostile takeover (like poison pills) which likely would hurt stockholders
website points out NNLX has exclusive license to flat pack tech and similar group apparently involved in
n assay-so reason or proof yet shown that would indicate that NNLX does not have exclusive license to n assay also== this forces big co's to play fairly and not via hostile takeover in negotiations w NNLX
No BOD elections
-see comments on shareholder meetings-and dont think anything of substance will openly be discussed in any meeting where mgmt senses rebellion- mgmt will immediately go into executive session in which non-board members will be excluded-so b/d elections are usually mere formalities also
, no financials, this isnt correct - its late financials which are very common to pennies,including sec reporting co's-I/m in an SEC co or 2 right now where no 10q or 10k since 2014 also-and as i explained at great length the financials are greatly outweighed by the n assay news etc
thanks for disliking almost every one of my posts-confirmation i havent gone over to the dark side
all the above are designed to distract from the n-assay progress
wake up man-the n assay is ground breaking
confirmation-
1)the peer review article was rated the #1 article out of over 100 articles'''i'll let the science guys expound on that
2) Dr Faros presentation was rated the best presentation at the conference and he won an award for such
pestilences and plagues -once arrogantly thought solved when antibiotics were new-are coming back w a vengeance-new plagues and pestilences including many thought gone forever
antibiotic resistance itself is becoming a 'plague' reported widely by the oligarchic secular press-despite the lack of immediate graphic mages so common to car train airplane wrecks and gas explosions etc -since their sick journalistic philosophy is, 'if it bleeds it leads"
but public tv cameras arent allowed in icu's or the secondary icu's where most deaths occur
by the time a non-accident is reported its of substantial magnitude
press has also reported cattle etc are infused w up to 17 kinds of antibiotics plus growth hormones (is this why the younger gen is taller despite the depleted food?) which are wreaking havoc in our bodies and creating antibiotic resistance
so the sick come in droves- americans are the sickest people on the planet because the profiteers have destroyed /depleted our food-(e.g.,it takes 45 bowls of spinach to equal the nutrition of 1 bowl in 1945) and immediate antibiotics cannot be administered without many days of waiting for sensitivity tests unless dr wants to risk lawsuit and if patient meanwhile dies dr faces lawsuit anyway in our entitled lawsuit society
so now the importance of the n- assay has been made known to a wider audience of peers the lawsuit angle alone should lead to its adoption
this is epic man- wakeup before its too late- dont let revenge control your entire life-it will only destroy you
8
1
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...
Continue Reading
Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...
Continue Reading
The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...
Continue Reading
Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...
Continue Reading
A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...
Continue Reading
Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...
Continue Reading
What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...
Continue Reading
Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...
Continue Reading
Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...
Continue Reading
Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...
Continue Reading
Top 5 Most Recently Viewed Articles
Nano Hearing Aids' Global Strategy: A Tour to Remember Nano Hearing Aids is taking significant strides in expanding its presence worldwide. As part of this vision, Ryan F. Zackon, the esteemed CEO, is setting out on an ambitious global tour. This initiative aims to deepen partnerships and solidify relationships within the hearing aid community. Tour Objectives: Fostering...
Continue Reading
The Impressive Journey of Toll Brothers Stock Toll Brothers (NYSE: TOL) has demonstrated remarkable resilience and growth over the past 15 years. With an average annual return of 14.07%, it has outperformed the market by 1.87%. As of now, the company's market capitalization stands at an impressive $12.22 billion. Investment Potential: What If You Bought $1,000? Imagine...
Continue Reading
DigiKey to Showcase Automation Innovations at SPS 2025 Global distributor highlights extensive range of industrial automation products available in Europe THIEF RIVER FALLS, Minn. — DigiKey, a renowned global distributor of electronic components and automation solutions, invites attendees of the Smart Production Solutions (SPS) conference to visit its booth, #106 in...
Continue Reading
Exciting Progress for CDI-988 in Clinical Trials Cocrystal Pharma, Inc. (NASDAQ: COCP) recently shared encouraging findings from its Phase 1 study of CDI-988, an innovative pan-viral inhibitor, during the Military Health System Research Symposium. This multi-day event focused on advancing military medical care, with Cocrystal presenting influential data that showcases the...
Continue Reading
Introduction to the Estelle Project Nova Minerals Limited (NASDAQ: NVA) has recently reported significant support for its Estelle Gold and Critical Minerals Project from Alaska State government officials and representatives from the Australian Consulate. These interactions highlight the growing recognition of the Estelle Project as crucial for the development of both...
Continue Reading